References
Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–7.
Do SK, Jeong JY, Lee SY, et al. Glucose transporter 1 gene variants predict the prognosis of patients with early-stage non-small cell lung cancer. Ann Surg Oncol. 2018;25:3396–3403.
Goodwin J, Neugent ML, Lee SY, et al. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat. Commun. 2017;8:15503.
Lee SY, Jin CC, Choi JE, et al. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer. Sci Rep. 2016;6:35603.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
Shin Yup Lee and Jae Yong Park have no conflicts of interest to disclose.
Additional information
ASO Author Reflections is a brief invited commentary on the article, Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-Small Cell Lung Cancer. Ann Surg Oncol. 2018;25:3396–3403.
Rights and permissions
About this article
Cite this article
Lee, S.Y., Park, J.Y. GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer. Ann Surg Oncol 25 (Suppl 3), 948–949 (2018). https://doi.org/10.1245/s10434-018-6847-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6847-1